TG THERAPEUTICS INC revenue breakdown overview

TG THERAPEUTICS INC revenue for the last year amounted to 317.81 M EUR, the most of which — 317.81 M EUR — came from its highest performing source at the moment, Novel Treatments for B-cell Diseases, the year earlier bringing 211.70 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought TG THERAPEUTICS INC 317.81 M EUR, and the year before that — 211.70 M EUR.